中国药物评价
中國藥物評價
중국약물평개
Chinese Journal of Drug Evaluation
2015年
5期
262-265
,共4页
赵晔%葛龙%张珺%刘娟%张菊霞%田金徽
趙曄%葛龍%張珺%劉娟%張菊霞%田金徽
조엽%갈룡%장군%류연%장국하%전금휘
单个病例数据%系统评价%Meta分析%报告规范%系统评价和Meta分析优先报告的条目( PRISMA)
單箇病例數據%繫統評價%Meta分析%報告規範%繫統評價和Meta分析優先報告的條目( PRISMA)
단개병례수거%계통평개%Meta분석%보고규범%계통평개화Meta분석우선보고적조목( PRISMA)
Individual Participant Data%Systematic Review%Meta-analysis%Reporting Statement%Preferred reporting items for sys-tematic review and Meta-analysis( PRISMA)
2015年,单个病例数据系统评价/Meta分析优先报告条目(Preferred Reporting Items for a Systematic Reviewand Meta-a-nalysis of Individual Participant Data, PRISMA-IPD)声明的推出对单个病例数据系统评价/Meta分析( Systematic Reviews and Meta-analyses of Individual Patient Data)的规范报告将会发挥重要的作用。本文旨在对PRISMA-IPD声明形成的背景、过程及其内容和要求进行介绍。
2015年,單箇病例數據繫統評價/Meta分析優先報告條目(Preferred Reporting Items for a Systematic Reviewand Meta-a-nalysis of Individual Participant Data, PRISMA-IPD)聲明的推齣對單箇病例數據繫統評價/Meta分析( Systematic Reviews and Meta-analyses of Individual Patient Data)的規範報告將會髮揮重要的作用。本文旨在對PRISMA-IPD聲明形成的揹景、過程及其內容和要求進行介紹。
2015년,단개병례수거계통평개/Meta분석우선보고조목(Preferred Reporting Items for a Systematic Reviewand Meta-a-nalysis of Individual Participant Data, PRISMA-IPD)성명적추출대단개병례수거계통평개/Meta분석( Systematic Reviews and Meta-analyses of Individual Patient Data)적규범보고장회발휘중요적작용。본문지재대PRISMA-IPD성명형성적배경、과정급기내용화요구진행개소。
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data ( PRISMA-IPD) State-ment will normalize the report and improve the quality of systematic reviews and Meta-analyses of individual patient data.Current study aims to introduce the background, process of forming and the contents of PRISMA-IPD.